Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · FY 2026

Odyssey Health FY 2026 Results: Net Loss of $5.73M, Loss Widens

Odyssey Health, Inc. reported material weaknesses in its internal control over financial reporting as of July 31, 2026, specifically regarding the application of GAAP rules. The company faces significant risks related to its ability to fund operations, manage growth, and obtain FDA clearances for its medical product candidates.

FY 2026 at a glance · $ million · annual
MetricFY 2026FY 2025
Net income-5.7-1.7
EPS (diluted, $ a share)$-0.05$-0.02

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-K filed with the SEC, OTC: ODYY. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Odyssey Health, Inc.: key numbers

Share price
$0.0080Close, Nov 13
Market cap
$882K
Shares outstanding
110.22MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Odyssey Health, Inc.

All →
5:10 PM ET 8-K
Loan & Debt

Odyssey Health Debt Financing Update with LGH Investments, LLC

Odyssey Health, Inc. entered into amendments for two existing promissory notes with LGH Investments, LLC and Peter J. D’Arruda. The amendments extend the maturity dates of both notes to January 31, 2027, while maintaining all other existing terms and conditions.

Counterparty
LGH Investments, LLC
Term
through Jan 2027

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.